Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
about
Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1.Hypoxia-Mimicking Nanofibrous Scaffolds Promote Endogenous Bone Regeneration.Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice.Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.Micro-CT - a digital 3D microstructural voyage into scaffolds: a systematic review of the reported methods and resultsTargeting the Cellular “Oxygen Sensors”: Hypoxia Pre-Conditioning and Stabilization of Hypoxia-Inducible Factors
P2860
Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Deferoxamine released from poly
@nl
Deferoxamine released from pol ...... angiogenesis and osteogenesis.
@en
type
label
Deferoxamine released from poly
@nl
Deferoxamine released from pol ...... angiogenesis and osteogenesis.
@en
prefLabel
Deferoxamine released from poly
@nl
Deferoxamine released from pol ...... angiogenesis and osteogenesis.
@en
P2093
P2860
P356
P1476
Deferoxamine released from pol ...... angiogenesis and osteogenesis.
@en
P2093
Han Bing Zhou
Lian Fu Deng
Nian Dong Qian
P2860
P304
P356
10.1002/JBM.A.35793
P577
2016-05-26T00:00:00Z